We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-5 of 5

Bulldog II: SJC eliminates First Amendment challenge to securities violations found by the Massachusetts Securities Division
  • Foley Hoag LLP
  • USA
  • September 28 2011

A decision by the Massachusetts Supreme Judicial Court (“SJC”) on September 22, 2011, lays to rest the Secretary of the Commonwealth’s finding that a hedge fund manager, Bulldog Investors General Partnership (“Bulldog”), and its principals, violated the Massachusetts Securities Act through its operation of an interactive website that provided investment information to all visitors.


Secretary Galvin proposes expert network regulations for Massachusetts advisers
  • Foley Hoag LLP
  • USA
  • April 21 2011

Secretary of the Commonwealth William Francis Galvin has proposed regulations to add conditions to the use of "matching or expert network services" by investment advisers which are registered in Massachusetts or operating in Massachusetts within an exemption from registration.


Qui Tam? Now more plaintiffs will qualify
  • Foley Hoag LLP
  • USA
  • April 7 2010

An important mechanism for bringing suit against healthcare providers and pharmaceutical and medical device companies the Qui Tam Action has been expanded as part of the Patient Protection and Affordable Care Act (Pub. L. No. 111-148) (the "PPACA").


Hedge funds join “the CEO’s brother-in-law” as the target of insider trading cases
  • Foley Hoag LLP
  • USA
  • November 9 2009

Insider trading cases often have focused on "the CEO’s brother-in-law" or similarly situated individuals who used a tidbit passed along at Thanksgiving dinner to make a quick and easy personal profit.


Medical devices play a large role in Massachusetts health care fraud unit cases: September 2008 September 2009
  • Foley Hoag LLP
  • USA
  • August 19 2009

A retrospective review of the cases brought by the Massachusetts U.S. Attorney’s Office Health Care Fraud Unit between September 2008 and September 2009 reveals a high number of cases involving medical devices as compared to drugs or other medical products.